Martindale: The Complete Drug Reference, 35th Edition 2 Volume Set

This book provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world. Each new drug licensed for use has its own potential benefits and adverse effects, and its own profile for dosage, administration and indications. Furthermore, manufacturers make regular changes to existing drug names and formulations, which can affect their interactions and safe usage. Health professionals require the correct answers and need to have confidence in the drugs information they use - but with medicines evolving at this rate, how can they be sure their knowledge is up to date? "Martindale" contains up to date information about more than 5,800 substances. Each and every entry is reviewed by our pharmaceutical editors to ensure health professionals have the most current data. Formulations change. Definitions change. Names change. But you can always trust "Martindale".

Martindale provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world – no other source has the breadth and depth of coverage. · Encyclopaedic facts about drugs and medicines - 5,500 drug monographs - 128,000 preparations - 40,700 reference citations - 10,900 manufacturers · Synopses of disease treatments · Enables identification of medicines, the local equivalent and the manufacturer · Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines · Based on published information and extensively referenced New for the thirty-fifth edition · Chapters reorganised to better reflect the clinical use of drugs · International Nonproprietary Names now in English, French, Latin, Russian and Spanish · Increase in synonyms from Scandinavia, Baltic and Eastern European areas · Increased coverage of ‘street names’ for drugs and substances liable to abuse · Indication of drugs restricted or banned by sports authorities · Molecular structural formulae included for selected drugs · Coverage of proprietary preparations expanded to 36 countries, now including Czech Republic, Hungary, Russia and Venezuela